Addendum: Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference center

Marie-Luise Hilbers; Regula Brändli; Beda Mühleisen; Sandra N. Freiberger; Joanna Mangana; Reinhard Dummer

doi:10.18632/oncotarget.28264

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Addendum:

Addendum: Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference center

PDF | How to cite

Oncotarget. 2022; 13:984-984. https://doi.org/10.18632/oncotarget.28264

Metrics: PDF 647 views | ?

Marie-Luise Hilbers¹, Regula Brändli², Beda Mühleisen¹, Sandra N. Freiberger³, Joanna Mangana¹ and Reinhard Dummer¹

¹Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
²Department of Dermatopediatrics, Children’s Hospital Zurich, Zurich, Switzerland
³Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland

Published: August 04, 2022

Copyright: © 2022 Hilbers et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Consent was added to this article: We have informed consent statements from all patients.

Original article: Oncotarget. 2021; 12:125–130. DOI: https://doi.org/10.18632/oncotarget.27854

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28264

Publication Alerts

Post-Publication Promotion

Publication Discount

Addendum:

Addendum: Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference center